In the final episode, Overcoming Barriers and Future Integration of Subcutaneous Therapies in Lung Cancer, the panelists ...
Glenis Scadding still remembers one of her first patients for sublingual immunotherapy, forty years later. His hay fever was ...
Dr Reddy’s Labs launches India’s first DCGI-approved semaglutide injection ‘Obeda’ for type 2 diabetes: Our Bureau, Mumbai Saturday, March 21, 2026, 13:30 Hrs [IST] Dr Red ...
Dr. Reddy’s Laboratories has launched ‘Obeda’, an injectable semaglutide therapy for diabetes and weight management in India.
Nordisk’s India managing director told ThePrint, his company has now moved to higher-dose Semaglutide, oral formulations and ...
A Florida woman was convicted in connection with the death of a social media model to whom she had given silicone injections, ...
A randomized trial finds weekly extended-release buprenorphine yields neonatal outcomes comparable to sublingual treatment.
The newly approved mosunetuzumab for relapsed/refractory follicular lymphoma improves clinic efficiency and patient ...
T he recent reimbursement of Bimzelx (bimekizumab) in Ireland represents an important step forward in access to treatment for ...
India's diabetes burden has risen markedly, with 101 million individuals living with diabetes1. The clinical burden is ...
The signs of Western cultural suicide are alarming, yet there are some positive signals as well. The Trump administration is still trying to break apart the bloated Department of Education piece by ...